Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-25T07:41:13.651Z Has data issue: false hasContentIssue false

Vascular effects of topical oxymetazoline on human nasal mucosa

Published online by Cambridge University Press:  29 June 2007

M. Bende*
Affiliation:
Skövde, Sweden
S. Löth
Affiliation:
Skövde, Sweden
*
Mats Bende, M. D., ENT-dept, Central Hospital, S-541 85 Skövde, Sweden.

Abstract

Oxymetazoline, a derivative of imidazoline, is a widely used nasal decongestant. In contrast to other topical decongestants related to phenylephrine, sympathomimetic amines, it also induced a reduced nasal mucosal blood flow. The purpose of the present investigation was to evaluate the duration of effect of oxymetazoline on nasal airway resistance and mucosal blood flow. During the eight hours of study, the blood flow was reduced by 30–40 per cent in six hours. A similar decongestant effect of about 30 per cent was found during the same interval. The pharmacological profile of oxymetazoline seems questionable, since a reduced nasal mucosal blood flow might not be of value in the treatment of upper airways infections.

Type
Research Article
Copyright
Copyright © JLO (1984) Limited 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andersson, K. E. and Bende, M. (1984) Adrenoceptors in the control of human nasal mucosal blood flow. Annals of Otology, Rhinology and Laryngology, 93: 179182.CrossRefGoogle ScholarPubMed
Änggárd, A. (1974) Autonomic nervous control of blood circulation and secretion in the nasal mucosa. An experimental study in the cat. Thesis. Karolinska Instituted, Stockholm.Google Scholar
Bende, M. (1983) The effect of topical decongestant on blood flow in normal and infected nasal mucosa. Acta Otolaryngologica (Stockholm), 96: 523527.CrossRefGoogle ScholarPubMed
Bende, M., Flisberg, K., Larsson, I., Ohlin, P. and Olsson, P. (1983) A method of determination of blood flow with 133Xe in human nasal mucosa. Acta Otolaryngologica (Stockholm), 96: 277285.CrossRefGoogle ScholarPubMed
Broms, P., Jonson, B. and Lamm, C. J. (1982) Rhinomanometry. A system for numerical description of the nasal airway resistance. Acta Otolaryngologica (Stockholm), 94: 157168.CrossRefGoogle ScholarPubMed
Cole, P., Fastag, O. and Forsyth, R. (1980) Variability in nasal resistance measurements. Journal of Otolaryngology, 9: 309315.Google ScholarPubMed
Drettner, B. (1961) Vascular reactions of the human nasal mucosa on exposure to cold. Acta Otolaryngologica (Stockholm), Supplement 166.Google Scholar
Knothe, J. von and Rietschel, M. (1976) Vergleichende Untersuchung zum therapeutischen Effekt ver-schiedener Antirihinitika. Das Deutsche Gesundheitswesen, 31: 12.Google Scholar
Kuhn, A. J. (1966) Evaluation of a new topical nasal decongestant. Journal of Indiana State Medical Association, 59: 12951296.Google ScholarPubMed
Kully, B. M. (1945) The use and abuse of nasal vasoconstrictor medications. JAMA, 127: 307310.CrossRefGoogle Scholar
Malm, L. (1977) Sympathetic influence on the nasal mucosa. Acta Otolaryngologica (Stockholm), 83: 2021.CrossRefGoogle ScholarPubMed
Mayer, P. S. (1966) A prolonged acting topical nasal decongestant for various rhinitides. Illinois Medical Journal, 129: 230.Google ScholarPubMed
Meurman, O. H. and Rantanen, T. (1975) A controlled clinical comparison of nasal decongestants in acute rhinitis. Journal of International Medical Research, 3: 356362.CrossRefGoogle Scholar
Miller, J. (1964) Oxymetazoline in allergic rhinitis. Clinical Medicine, 09: 15611564.Google Scholar
Mygind, N. (1979) Conventional medical treatment. In: Nasal allergy, Blackwell Scientific Publications, Oxford.Google Scholar
Wihl, J. Å. (1978) Kan 'perorala näsdroppar' ersätta lokalbehandling med näsdroppar? Draco pro Medico, 5: 12.Google Scholar